- Home
- CLDX vs BDJ Comparison
CLDX vs BDJ Comparison
Compare CLDX & BDJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- BDJ
- Stock Information
- Founded
- CLDX N/A
- BDJ 2005
- Country
- CLDX United States
- BDJ United States
- Employees
- CLDX N/A
- BDJ N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- BDJ Finance Companies
- Sector
- CLDX Health Care
- BDJ Finance
- Exchange
- CLDX Nasdaq
- BDJ Nasdaq
- Market Cap
- CLDX 1.3B
- BDJ 1.5B
- IPO Year
- CLDX 2008
- BDJ N/A
- Fundamental
- Price
- CLDX $21.35
- BDJ $8.60
- Analyst Decision
- CLDX Buy
- BDJ
- Analyst Count
- CLDX 9
- BDJ 0
- Target Price
- CLDX $50.00
- BDJ N/A
- AVG Volume (30 Days)
- CLDX 1.0M
- BDJ 561.6K
- Earning Date
- CLDX 08-07-2025
- BDJ 01-01-0001
- Dividend Yield
- CLDX N/A
- BDJ 8.85%
- EPS Growth
- CLDX N/A
- BDJ N/A
- EPS
- CLDX N/A
- BDJ N/A
- Revenue
- CLDX $7,559,000.00
- BDJ N/A
- Revenue This Year
- CLDX N/A
- BDJ N/A
- Revenue Next Year
- CLDX N/A
- BDJ N/A
- P/E Ratio
- CLDX N/A
- BDJ N/A
- Revenue Growth
- CLDX 24.49
- BDJ N/A
- 52 Week Low
- CLDX $14.40
- BDJ $6.91
- 52 Week High
- CLDX $47.00
- BDJ $8.66
- Technical
- Relative Strength Index (RSI)
- CLDX 59.74
- BDJ 55.96
- Support Level
- CLDX $19.25
- BDJ $8.51
- Resistance Level
- CLDX $20.56
- BDJ $8.65
- Average True Range (ATR)
- CLDX 1.13
- BDJ 0.09
- MACD
- CLDX 0.04
- BDJ -0.00
- Stochastic Oscillator
- CLDX 97.22
- BDJ 79.63
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About BDJ Blackrock Enhanced Equity Dividend Trust
BlackRock Enhanced Equity Dividend Trust is a United States closed-end management investment company. Its investment objective is to seek current income and current gains, with a secondary objective of long-term capital appreciation.